Trial Profile
Clinical Trials Insight: 700035057
Status:
Not yet recruiting
Phase of Trial:
Phase III
Latest Information Update: 08 Jul 2008
Price :
$35
*
At a glance
- Drugs MGX 006 (Primary)
- Indications Nausea and vomiting
- Focus Registrational; Therapeutic Use
- Sponsors Victory Pharma
- 08 Jul 2008 New trial record.